Medicomunicare Magazine | Health and Medical News
In a clinical study just published in the New England Journal of Medicine, scientists have summarized the safety and efficacy profile of the SARS-CoV2 vaccine NVX-CoV2373 (Novavax). The findings reveal that the two-dose regimen of the vaccine is almost 90% effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Moreover, the vaccine shows high
Read More